Notification of change in the BASTA criteria from 01/01/2017 (published 12/15/2016)

During the criteria update 2015-06-01 criteria 17c (H413) were removed from the properties criteria. The reason for this change was the inconsistence that products which were classified as Hazardous to the aquatic environment in the categories Chronic 1, 2 and 4 could not be registered, but products classified as category Chronic 3 could.

Category Chronic 4 (H413) and categories Chronic 1 (H410): Very toxic to aquatic life with long lasting effects, were in connection with the Swedish Chemicals Agency’s latest update of the PRIO-criteria under CLP, included as risk reduction properties. However, the PRIO-criteria does not include category Chronic 2 (H411): toxic to aquatic life with long lasting effects, nor category Chronic 3 (H412): long-term adverse effects to aquatic organisms.

In the PRIO-criteria you will find two levels of prioritization; phasing out substances and priority risk reduction substances. Since BASTA should cover both phasing-out and risk reduction properties H413 will be reinstated into the BASTA properties criteria.

However, in practice, more than 90% of the hazardous substances in PRIO are classified as H410 (R50/53 of the DPD) and a fairly small part only H413 (R53 as a single phrase in DPD).

BASTA Methods of Calculation 2016-12-14

Clarification – criteria 5 in BASTA- and BETA-criteria

Substances with an overall assessment Cat 1 or Cat 2 in EG’s EDS Database and substances included on the candidates list with endocrine disrupting properties in accordance with REACH Article 57f.

Voluntary emission information

BASTA will from 1/1 2017  introduce a voluntary opportunity to present results from completed emissions measurements for building products intended for indoor use.

Building products should be emission tested with regards to the release of volatile and semiVOC, SVOC, and certain aldehydes according to the standard which CEN are expected to publish during the autumn (CEN 16516: 2015).

The documentation should be attached as a report of the completed emission measurement in accordance with the draft standard prCEN 16516: 2015.

When the documentation is attached enter the following information in the description field: The Emissions measurements are carried out in accordance with CEN standard 16516:2015. For more information see attached document.

Further information regarding Endocrine disrupting substances

We await with interest the European Commission’s new criteria for endocrine disruptors. It is desirable to use the upcoming EC-unified criteria as a foundation for BASTA:s-own criteria for endocrine disrupters. However, we deem that it is likely that during a transitional period we will continue to depend on lists to define endocrine disrupting substances.

The European Commission’s EDS database is the current list on which BASTA rest the criteria definitions of endocrine disrupters. This is a static list which no longer is updated which means that it does not include any new findings – the list may then contain substances no longer considered as endocrine disrupting substances or lack substances where recent research has been proven endocrine disrupting properties.

We are therefore investigating possible alternatives or complements available with regards to the EDS database. IPCP (International Panel on Chemical Pollution) has been commissioned by the UN agency UNEP to compile an evaluation report regarding endocrine disruptors. A draft of this report is available on the UNEP website. (http://wedocs.unep.org/handle/20.500.11822/12218)

The report selects a number of substances that meets the WHO definition of endocrine disruptors and where the scientific evidence has been evaluated and deemed credible. When the final version of the IPCP-report is published BASTA will assess the possibility of using the IPPC report as a supplement or replacement for EDS database.

If the evaluation of IPCPs report indicates that it is a suitable replacement or complement to the EDS database as the foundation for BASTA endocrine disrupter criteria, changes will be notified at least six months in advance of implementation.

Best wishes,
Sussi Wetterlin and Anna Widheden
BASTAonline AB